PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
60.35
ESG score near Healthcare median of 61.05. David Dodd would investigate if industry-standard ESG practices adequately address sector-specific risks.
57.07
Environmental score near Healthcare median of 57.98. David Dodd would investigate if industry-standard environmental practices adequately address climate risks.
60.74
Social score near Healthcare median of 63.25. David Dodd would investigate if industry-standard social practices adequately address stakeholder risks.
63.25
Governance score near Healthcare median of 61.66. David Dodd would investigate if industry-standard governance adequately protects shareholder interests.